Invention Grant
- Patent Title: Indolizine derivatives and their application in medicine
-
Application No.: US17239362Application Date: 2021-04-23
-
Publication No.: US11655249B2Publication Date: 2023-05-23
- Inventor: Dong Liu , Dongdong Chen , Biao Deng , Xiangyun Tu , Zinan Fang , Haohao Wu , Danyan Gu
- Applicant: Kind Pharmaceutical
- Applicant Address: CN Hangzhou
- Assignee: KIND PHARMACEUTICAL
- Current Assignee: KIND PHARMACEUTICAL
- Current Assignee Address: CN Zhejiang
- Agency: Bozicevic, Field & Francis LLP
- Agent James S. Keddie
- Priority: CN 1710322377.2 2017.05.09
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61P7/00 ; C07D491/20

Abstract:
This invention relates to indolizine derivatives and their use in medicine. In particular, the present invention discloses novel substituted indolizine derivatives of formula I, or an isotopically labeled compound thereof, or an optical isomer thereof, a geometric isomer thereof, a tautomer thereof or a mixture of various isomers, or a pharmaceutically acceptable salt thereof, or a prodrug thereof. The invention also relates to the use of these compounds in medicine.
Public/Granted literature
- US20210253570A1 INDOLIZINE DERIVATIVES AND THEIR APPLICATION IN MEDICINE Public/Granted day:2021-08-19
Information query